Home World News FDA Approves Sotorasib with Panitumumab for KRAS G12C-mutated Colorectal Cancer World News FDA Approves Sotorasib with Panitumumab for KRAS G12C-mutated Colorectal Cancer By Ogkologos - February 13, 2025 799 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the CodeBreaK 300 study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR New on NCI’s Websites for March 2023 March 24, 2023 Many Patients with NSCLC Show Targetable Alterations in the PI3K Pathway March 24, 2021 Physicians Debate Recent FDA Approval of an Immune Checkpoint Inhibitor in... March 31, 2021 35-Year-Old Mom Has Been Living With Stage IV Breast Cancer For... March 25, 2020 Load more HOT NEWS Her Wedding Ceremony Was Interrupted By A Voice In The Back,... Talquetamab Continues To Demonstrate High Overall Response Rates in Heavily Pretreated... A Congress Bag for Women’s Empowerment Five Questions With…Desiree.
